{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Results will be presented with descriptive statistics.","groups":[{"description":"Patients receive xisomab 3G3 IV or via catheter within 48 hours of catheter placement. Patients then receive standard of care chemotherapy 2 days later. After approximately 2 weeks, patients undergo standard of care ultrasound for possible CAT.\n\nXisomab 3G3: Given IV or via catheter","id":"OG000","title":"Supportive Care (Xisomab 3G3)"}],"populationDescription":"No participants developed catheter occlusion requiring medical intervention prior to the end of treatment visit.","reportingStatus":"POSTED","timeFrame":"Up to end of treatment visit (day 18)","title":"Proportion of Patients That Had a Catheter Occlusion Requiring Medical Intervention","type":"OTHER_PRE_SPECIFIED"}